Evidence map›Paper›PMID 39458633›Full record

ArticlePharmaceutics2024

Stable Polymer-Lipid Hybrid Nanoparticles Based on

Sergey M Shishlyannikov, Ilya N Zubkov, Vera V Vysochinskaya, Nina V Gavrilova, Olga A Dobrovolskaya, Ekaterina A Elpaeva, Mikhail A Maslov, Andrey Vasin

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Nano-Based Technology in Glioblastoma.Molecules (Basel, Switzerland) · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sergey M ShishlyannikovInstitute of Biomedical Systems and Biotechnology, Peter the Great Saint Petersburg Polytechnic University, 29 Politechnicheskaya St., 195251 Saint Petersburg, Russia.ORCID 0000-0002-6377-7445
Ilya N ZubkovInstitute of Biomedical Systems and Biotechnology, Peter the Great Saint Petersburg Polytechnic University, 29 Politechnicheskaya St., 195251 Saint Petersburg, Russia.
Vera V VysochinskayaInstitute of Biomedical Systems and Biotechnology, Peter the Great Saint Petersburg Polytechnic University, 29 Politechnicheskaya St., 195251 Saint Petersburg, Russia.
Nina V GavrilovaInstitute of Biomedical Systems and Biotechnology, Peter the Great Saint Petersburg Polytechnic University, 29 Politechnicheskaya St., 195251 Saint Petersburg, Russia.ORCID 0000-0002-7825-9130
Olga A DobrovolskayaSmorodintsev Research Institute of Influenza, 15/17 Prof. Popova Street, 197022 Saint Petersburg, Russia.ORCID 0000-0001-6654-1107
Ekaterina A ElpaevaSmorodintsev Research Institute of Influenza, 15/17 Prof. Popova Street, 197022 Saint Petersburg, Russia.
Mikhail A MaslovM.V. Lomonosov Institute of Fine Chemical Technologies, Rtu Mirea, 86 Vernadsky Ave., 119454 Moscow, Russia.ORCID 0000-0002-5372-1325
Andrey VasinInstitute of Biomedical Systems and Biotechnology, Peter the Great Saint Petersburg Polytechnic University, 29 Politechnicheskaya St., 195251 Saint Petersburg, Russia.ORCID 0000-0002-1391-7139

Funding

Russian The research was supported by Russian Science Foundation 23-25-00165
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cationic liposomeionic strengthmcl-polyhydroxyalkanoatemRNA transfectionpolymer–lipid nanoparticles

Identifiers

PMID39458633
PMCPMC11511049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.